Throdahl Mark C 4
4 · ORTHOPEDIATRICS CORP · Filed May 21, 2020
Insider Transaction Report
Form 4
Throdahl Mark C
Director
Transactions
- Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+402$12,450→ 156,420 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−670$20,750→ 0 totalExercise: $30.97Exp: 2020-09-02→ Common Stock (670 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−402$12,450→ 0 totalExercise: $30.97Exp: 2022-08-23→ Common Stock (402 underlying) - Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+670$20,750→ 155,616 total - Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+402$12,450→ 156,018 total - Sale
Common Stock
2020-05-20$46.56/sh−670$31,195→ 156,152 total - Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+402$12,450→ 156,822 total - Sale
Common Stock
2020-05-20$46.56/sh−402$18,717→ 155,348 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−402$12,450→ 0 totalExercise: $30.97Exp: 2021-08-03→ Common Stock (402 underlying) - Sale
Common Stock
2020-05-20$46.56/sh−402$18,717→ 155,750 total - Sale
Common Stock
2020-05-20$46.57/sh−402$18,721→ 154,946 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−402$12,450→ 0 totalExercise: $30.97Exp: 2023-09-10→ Common Stock (402 underlying)
Footnotes (1)
- [F1]The stock option is fully vested and immediately exercisable.